Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04803604 · ClinicalTrials.gov registry record · NA

Decision Support Training for Advanced Cancer Family Caregivers: The CASCADE Factorial Trial

A NA study of Cancer and Family Members, sponsored by University of Alabama at Birmingham.

Active
Registry status
NA
Development phase
256
Enrollment target
2
Study locations

NCT04803604: Active NA study of Cancer and Family Members, sponsored by University of Alabama at Birmingham.

NCT04803604 is a NA study of Cancer and Family Members that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 256 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04803604, a NA study of Cancer and Family Members, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
256 participants
Enrollment target
2
Study locations

Study Summary

Using a highly innovative methodology, the Multiphase Optimization Strategy (MOST), the purpose of this randomized factorial trial is to identify components of a intervention (CASCADE) to enhance the decision support skills of family caregivers of persons with newly-diagnosed advanced cancer. Using a 2x2x2x2 full factorial design, 256 family caregivers of persons with newly-diagnosed advanced cancer will be randomized to receive one or more nurse coach-delivered decision partnering training components, based on the Ottawa Decision Support Framework and Social Support Effectiveness Theory: 1) psychoeducation on effective decision partnering principles (1 vs. 3 sessions); 2) decision partnering communication training (yes vs. no); 3) Ottawa Decision Guide training (yes vs. no); and monthly follow (1 monthly follow-up call vs. monthly follow-up calls for 24 weeks).

Primary Outcome

16-item measure; perceptions of uncertainty in choosing options, factors contributing to uncertainty (e.g., feeling uninformed, unclear values) and feeling that decisions were informed and values-based.

Conditions Studied

Interventions

  • BEHAVIORAL CASCADE (CAre Supporters Coached to be Adept DEcision partners)

Study Locations (2)

Alabama

  • University of Alabama at Birmingham - Birmingham

Georgia

  • Emory University - Atlanta

Trial Details

FieldValue
Enrollment Target 256 participants
Start Date 2022-01-10
Est. Completion 2026-06-30
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the registry record for NCT04803604 still lists

NCT04803604 is an interventional study that assigns participants to a tested intervention. The registered 256 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower).

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which CASCADE (CAre Supporters Coached to be Adept DEcision partners) is the first listed.

NCT04803604 reports a single indexed study location in Alabama, Georgia.

Frequently Asked Questions

What is clinical trial NCT04803604 about?

NCT04803604 is a clinical study titled "Decision Support Training for Advanced Cancer Family Caregivers: The CASCADE Factorial Trial". Using a highly innovative methodology, the Multiphase Optimization Strategy (MOST), the purpose of this randomized factorial trial is to identify components of a intervention (CASCADE) to enhance the decision support skills of family caregivers of persons with newly-diagnosed advanced cancer. Using ...

What is the current status of trial NCT04803604?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 256 participants. The study started on 2022-01-10. Estimated completion is 2026-06-30.

What conditions does trial NCT04803604 study?

This clinical trial studies the following conditions: Cancer, Family Members.

What interventions are being tested in trial NCT04803604?

The interventions under investigation include: CASCADE (CAre Supporters Coached to be Adept DEcision partners) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04803604?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04803604 being conducted?

This trial has 2 study locations across Alabama, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04803604's enrollment target sits among peer trials

256 204th of 615 higher than 412 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02464696 · 256 participants · NA

    Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure

  • NCT03793062 · 256 participants

    Genetic and Epigenetic Basis of Chronic Wounds

  • NCT04322318 · 256 participants · Phase 2

    A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

  • NCT04468360 · 256 participants · Phase 2

    Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04803604, the US trial registry maintained by the National Library of Medicine. NCT04803604 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.